1,382 top medical experts on Lymphoproliferative Disorders across 45 countries and 36 U.S. states, including 1,331 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Lymphoproliferative Disorders: Disorders characterized by proliferation of lymphoid tissue, general or unspecified.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Lymphatic Diseases (4,615), Immunoproliferative Disorders (78) and Narrower Categories: Agammaglobulinemia (1,263), Autoimmune Lymphoproliferative Syndrome (1,059), Castleman Disease (4,074), Granuloma (2,116), Hairy Cell Leukemia (1,956), Heavy Chain Disease (297), Immunoblastic Lymphadenopathy (1,201), Immunoglobulin Light-chain Amyloidosis (932), Immunoproliferative Small Intestinal Disease (89), Infectious Mononucleosis (1,650), Lymphangiomyoma (92), Lymphoid Leukemia (1,320), Lymphoma (3,090), Macrophage Activation Syndrome (1,834), Multiple Myeloma (5,017), Plasmacytoma (3,837), Sarcoidosis (3,491), Sezary Syndrome (1,958), Tumor Lysis Syndrome (1,322), Waldenstrom Macroglobulinemia (1,325).
  4. Clinical Trials ClinicalTrials.gov : at least 203 including 16 Active, 87 Completed, 41 Recruiting
  5. Synonyms: Duncan's Syndrome,  X-Linked Lymphoproliferative Syndrome


  

        

                    


    Computing Expert Listing ...

);